Mercer Global Advisors
RVMD icon

Mercer Global Advisors’s Revolution Medicines RVMD Stock Holding History

Mercer Global Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Buy
+17,436
New +$2.55M ﹤0.01% 1081
2025
Q4 		– Sell
-6,002
Closed -$280K – 2954
2025
Q3 		$280K Buy
+6,002
New +$235K ﹤0.01% 2139

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mercer Global Advisors's RVMD Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 17,436 shares worth $3.27M. The stake represents ﹤0.01% of the portfolio and ranks #1081 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in RVMD as recently as Q3 2025.

Mercer Global Advisors first reported a position in RVMD in Q3 2025 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mercer Global Advisors held 17,436 shares of Revolution Medicines worth $3.27M as of Q2 2026.
  • Revolution Medicines was a new Mercer Global Advisors position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1081 holding.
  • Mercer Global Advisors first reported a position in Revolution Medicines in Q3 2025 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.